GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA

Karmali, R. ; Chukkapalli, V. ; Pro, B. ; Borgia, J.A. ; Mazar, A. ; Ugolkov, A. ; Giles, F.J.

Hematological oncology, 2017-06, Vol.35 (S2), p.400-402 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível